# A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)

> **NCT07680907** · — · NOT_YET_RECRUITING · sponsor: **Janssen-Cilag Farmaceutica Ltda.** · enrollment: 250 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07680907
- **Lead sponsor:** Janssen-Cilag Farmaceutica Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-31
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680907, "A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*